RxDoctor Payments Data

Jacob Urda, DO

Family Medicine · Crestview, FLNPI 1427445477

Payments from drug & device makers

$4,761in general payments, 2019–2025

Across 281 payments — averaging $16.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$847
  • AstraZeneca$820
  • Novo Nordisk$778
  • AbbVie$469
  • Lilly USA, LLC$397
  • Boehringer Ingelheim$306
  • plus $1K from 23 others

What the payments were for

  • Food & beverage$4,761100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,761 in reported general payments places this provider in the 85th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$307,248
Medicare patients
412
Services billed
4,682

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter153$169,616
MounjaroTirzepatide112$159,178
OzempicSemaglutide92$158,775
JardianceEmpagliflozin112$113,883
FarxigaDapagliflozin Propanediol84$99,534
Breztri AerosphereBudesonide/Glycopyr/Formoterol66$63,825
JanuviaSitagliptin Phosphate55$61,758
EliquisApixaban57$58,694
TrulicityDulaglutide33$48,324
VraylarCariprazine Hcl21$36,192
EntrestoSacubitril/Valsartan29$31,486
MyrbetriqMirabegron33$20,810
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr29$17,640
Tresiba Flextouch U-100Insulin Degludec11$16,230
Repatha SureclickEvolocumab18$12,830

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$397$207,501145 claims
GSKTrelegy Ellipta, Anoro Ellipta$847$187,256182 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$820$167,224166 claims
Novo NordiskOzempic, Fiasp$778$164,756103 claims
Boehringer IngelheimJardiance$306$113,883112 claims
MerckJanuvia$100$61,75855 claims
PfizerEliquis$68$58,69457 claims
AbbVieVraylar, Ubrelvy$469$46,16234 claims
NovartisEntresto$21$31,48629 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Crestview

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →